Live Analyst Rating Changes 23245 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ann Hynes
MIZU

Ann Hynes

Mizuho Securities
Wall Street Analyst
★★★★★
#256
on 13Foresight · ranked by our own returns
67%
Success Rate
+8.8%
Average Return
47 of 70 calls profitable · +4.6% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 67% of Ann Hynes's ratings turned a profit when each position was held for 1 year — averaging +8.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

119 Buy 37 Hold 0 Sell
Ann's Stock Coverage 31 ratings · 2026-08-12
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
LH
Labcorp Holdings
 Aug 10, 2026 BUY Strong Buy
-15.8% avg upside
37 analysts
$355.00
10.18% Upside
 +0.0% ·
CRL
Charles River Labs
 Aug 10, 2026 HOLD Strong Buy
-16.3% avg upside
35 analysts
$264.00
6.40% Downside
 +1.8% ·
CON
Concentra Group Holdings Parent, Inc.
 Aug 10, 2026 BUY Strong Buy
+14.4% avg upside
12 analysts
$40.00
21.16% Upside
 · ·
THC
Tenet Healthcare
 Aug 10, 2026 BUY Strong Buy
-8.5% avg upside
27 analysts
$290.00
11.85% Upside
 +0.0% ·
ARDT
Ardent Health Partners, Inc.
 Aug 06, 2026 BUY Buy
+26.9% avg upside
16 analysts
$13.00
18.47% Upside
 -4.6% ·
FTRE
Fortrea Holdings Inc.
 Jul 31, 2026 HOLD Buy
+8.0% avg upside
12 analysts
$19.00
2.68% Downside
 -0.9% ·
IQV
IQVIA Holdings
 Jul 31, 2026 BUY Strong Buy
-0.4% avg upside
39 analysts
$275.00
12.70% Upside
 +2.9% ·
BTSG
BrightSpring Health Services, Inc.
 Jul 31, 2026 BUY Strong Buy
+12.2% avg upside
20 analysts
$86.00
48.60% Upside
 -2.9% ·
DGX
Quest Diagnostics
 Jul 28, 2026 BUY Buy
-22.7% avg upside
34 analysts
$260.00
9.50% Upside
 +1.0% ·
HCA
HCA Healthcare
 Jul 28, 2026 BUY Buy
-0.9% avg upside
36 analysts
$475.00
15.54% Upside
 -0.9% ·
MEDP
Medpace Holdings
 Jul 28, 2026 BUY Buy
-19.9% avg upside
17 analysts
$665.00
9.74% Upside
 +4.9% ·
UNH
UnitedHealth
 Jul 21, 2026 BUY Strong Buy
+12.9% avg upside
36 analysts
$493.00
22.64% Upside
 -7.3% ·
MOH
Molina Healthcare
 Jul 13, 2026 BUY Buy
+21.1% avg upside
26 analysts
$255.00
31.00% Upside
 -15.2% ·
ACHC
Acadia Healthcare
 Jul 13, 2026 HOLD Strong Buy
+33.6% avg upside
17 analysts
$31.00
0.26% Downside
 +3.2% ·
CNC
Centene
 Jul 13, 2026 HOLD Buy
+9.8% avg upside
29 analysts
$69.00
6.34% Upside
 -1.8% ·
CVS
CVS Health
 Jul 13, 2026 BUY Strong Buy
+12.8% avg upside
39 analysts
$120.00
28.35% Upside
 -11.2% ·
HUM
Humana
 Jul 13, 2026 BUY Strong Buy
+12.0% avg upside
34 analysts
$468.00
25.57% Upside
 -5.2% ·
MD
Pediatrix Medical Group
 Jul 13, 2026 HOLD Buy
-14.8% avg upside
14 analysts
$27.00
3.27% Upside
 +3.6% ·
UHS
Universal Health
 Jul 13, 2026 BUY Buy
+16.3% avg upside
22 analysts
$200.00
18.59% Upside
 +13.6% ·
ELV
Elevance Health
 Jul 13, 2026 BUY Strong Buy
+15.0% avg upside
33 analysts
$470.00
20.32% Upside
 -6.1% ·
SGRY
Surgery Partners
 Jul 13, 2026 BUY Strong Buy
+47.9% avg upside
18 analysts
$19.00
26.68% Upside
 -2.8% ·
ICLR
Icon
 Jun 26, 2026 BUY Strong Buy
+13.8% avg upside
26 analysts
$190.00
14.72% Upside
 -1.6% ·
CI
Cigna
 Jun 08, 2026 BUY Strong Buy
+26.6% avg upside
29 analysts
$340.00
24.18% Upside
 -3.0% ·
EHC
Encompass Health
 Feb 09, 2026 BUY Strong Buy
-10.6% avg upside
22 analysts
$134.00
6.99% Upside
 +18.5% ·
COR
Cencora
 Mar 07, 2025 BUY Buy
-3.4% avg upside
44 analysts
 — +41.8% ·
MCK
McKesson
 Nov 06, 2024 HOLD Strong Buy
-15.1% avg upside
28 analysts
 — +57.0% ·
CAH
Cardinal Health
 Nov 04, 2024 HOLD Strong Buy
-16.8% avg upside
29 analysts
$110.00
54.13% Downside
 +77.1% ·
TFX
Teleflex
 Nov 08, 2022 HOLD Buy
+38.4% avg upside
20 analysts
$220.00
64.82% Upside
 +0.4% ·
MA
Mastercard
 Sep 12, 2022 BUY Strong Buy
+5.6% avg upside
54 analysts
 — +23.8% ·
CMS
CMS Energy
 Apr 11, 2022 BUY Strong Buy
+10.8% avg upside
21 analysts
 — -12.0% ·
CYH
Community Health
 Jul 27, 2018 HOLD Sell
+44.6% avg upside
18 analysts
$3.60
26.83% Upside
 -31.1% ·
🔒 26 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Ann Hynes — Frequently Asked Questions
How accurate are Ann Hynes's stock ratings?
Based on the calls 13Foresight could measure, about 67% of Ann's ratings were profitable over a one-year hold, with an average return of +8.7% per rating, or +4.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Ann ranked on 13Foresight?
Ann Hynes is currently ranked #256 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ann cover?
Ann most recently has ratings on LH, CRL, CON, THC, ARDT, FTRE, IQV, BTSG, DGX, HCA, MEDP, UNH and 19 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.